| Name | Title | Contact Details |
|---|
Somanetics Corporation is a Troy, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
"Eleven uses its proprietary technology platform to create first-of-a-kind protein therapeutics to address unmet needs for ophthalmic diseases. Proteins are able to modulate inflammatory cytokines, key targets in ocular disease that have been difficult to access with conventional therapeutic approaches. A significant untapped opportunity exists for protein therapeutics to address ophthalmic diseases, and Eleven is applying its advanced protein technology and expertise to develop innovative medicines for patients suffering from ocular diseases. Eleven`s team of industry veterans has deep experience in understanding protein science and biologic drug development, designing and conducting clinical trials and, most importantly, applying specific expertise in ophthalmic disease to create novel ocular therapeutics to treat unmet medical needs. Eleven has developed a proprietary pipeline of ophthalmic drug candidates derived from the company`s innovative AMP-Rx protein engineering technology. The company`s initial product candidates are focused on targeting inflammatory cytokines and key targets of ocular disease by blocking the cytokines and modulating the biological processes that drive ocular disease. Current pipeline opportunities include ocular surface diseases such as dry eye disease (DED) and allergic conjunctivitis (AC), and back of the eye diseases such as diabetic macular edema (DME) and uveitis. In addition, Eleven’s proprietary technology has been utilized to prolong the intravitreal half-life of our pipeline products. Beyond its internal drug development programs, Eleven works with collaborators, such as ThromboGenics, to apply its innovative protein therapeutic design capabilities to engineer and develop biotherapeutic products for additional therapeutic targets. EBI-005, Eleven`s lead product candidate, is a novel interleukin-1 (IL-1) receptor antagonist in Phase 3 clinical development as one of the first topically administered proteins for the treatment of DED and AC, two inflammatory diseases at the surface of the eye."
Stinger Medical is a Murfreesboro, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Seattle based Littlebird believes that building better connections and providing greater communication will lead to better results for you, your caregiver, and child. Littlebird`s state-of-the-art wearable device connects parents with their child anywhere, anytime, with on-demand information about who they are with, where they are located, what they are doing, and how they are feeling. Littlebird`s innovative technology and secure digital platform offers parents unique insights into their child`s safety, health and overall well-being. Littlebird`s 24/7 GPS and cellular connectivity enables up-to-date notifications regarding your child`s location, which "approved" caregiver they are with and what they are doing. Littlebird also provides key metrics regarding your child`s heartrate, daily activity, sleep patterns and much more so you can better understand your child`s specific needs. The intuitively designed app also provides a private chat with photo capabilities connecting you and your caregiver(s) so you never miss a moment of your toddler`s day.
Well Point is a Half Moon Bay, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.